Search Orphan Drug Designations and Approvals
-
Generic Name: | metformin |
---|---|
Date Designated: | 12/14/2017 |
Orphan Designation: | Treatment of progressive myoclonus epilepsy type 2 (Lafora disease) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Consorcio Centro de Investigación Biomédica en Red, M.P. (CIBER) Monforte de Lemos 3-5 Pabellon 11 Madrid, Comunidad de Madrid Spain The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-